Carvedilol sulfate

硫酸卡维地洛

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameCarvedilol sulfate
Drug Alias Name硫酸卡维地洛缓释(盐类改良新)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersBeta adrenergic receptors antagonistsAdrenergic receptor alpha-1 antagonists
TargetsBeta adrenergic receptorsVoltage-gated calcium channelAdrenergic receptors alpha-1
Therapy Area/IndicationsEssential HypertensionHeart FailureBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEgyptMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMansoura University
Inactive CompaniesJiangsu Hengrui Medicine Co Ltd
Active IndicationsBrain Injuries, Traumatic
Inactive IndicationsEssential HypertensionHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A